Flagship Private Wealth, LLC Abb Vie Inc. Transaction History

Flagship Private Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 20, 2021	SELL	$106.4 - $120.78 $64,372 - $73,071	-605 Closed	0 $0
Q2 2021 Jul 09, 2021	SELL	$105.21 - $117.21 $7.37 Million - $8.21 Million	-70,039 Reduced 99.14%	605 $70.6 Million
Q2 2021 Jul 09, 2021	BUY	$105.21 - $117.21 $7.37 Million - $8.21 Million	70,040 Added 11596.03%	70,644 $7.96 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $48,615 - $65,636	604 New	604 $64,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Flagship Private Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Private Wealth, LLC with notifications on news.